UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems
An in-cell method that sensitively detects rare off-target edits, benchmarks performance across editors, and improves risk assessment in therapeutic cells is presented, establishing UNCOVERseq as a robust framework for informed off-target risk assessment in translational gene-editing systems.